DexCom, Inc.
Market Cap
28B
Short interest (May 15)
4.6%
Net Short (Jun 03 ): 0.1%
Borrow Fee
0.30%
↑ 17.2%
Available Shares
5M
↓ 27.0%
Price Chart
Company Overview
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.